The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Janux Therapeutics Inc’s current trading price is -64.26% away from its 52-week high, while its distance from the 52-week low is 14.02%. The stock’s price range for this period has been between $22.48 and $71.71 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.61 million for the day, a number notably lower than the average daily volume of 1.0 million over the last three months.
Janux Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $71.71 on 12/05/24, while the lowest price for the same period was registered at $22.48 on 05/14/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Janux Therapeutics Inc (JANX) has experienced a quarterly decline of -23.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.52B and boasts a workforce of 81 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 34.19, with a change in price of -28.45. Similarly, Janux Therapeutics Inc recorded 999,214 in trading volume during the last 100 days, posting a change of -52.59%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for JANX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
JANX Stock Stochastic Average
Janux Therapeutics Inc’s raw stochastic average for the past 50 days is presently 27.57%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 27.57%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 23.75% and 22.27%, respectively.
JANX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -52.13% this year. Over the last six months, there has been a stronger performance of -47.70%. The price of JANX leaped by -20.08% during the last 30 days period. For the last 5-days stocks have improved 5.56%.
